BRAF Kinase Inhibitor Shrinks Melanoma Brain Metastases, Institute Gustave Roussy Study

Idsk -- MILAN (EGMN)–Hope for patients with melanoma who develop brain metastases may be on the horizon with the finding that a novel targeted agent reduces the size of multiple brain lesions.

MORE ON THIS TOPIC